Clinical Trial Update: Safety and Anti-HIV Activity of Capravirine Alone and in Combination With Other Anti-HIV Drugs [Phase 1]

View source ↗

Summary

A Phase 1 trial reports the safety and anti-HIV activity of capravirine alone and in combination with other HIV drugs in healthy volunteers and people with HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Capravirine (capravirine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Healthy, HIV Infection | Phase 1 | Status: COMPLETED